Vimarsana
Biggest News Aggregation in the World

Page 17 - Wang Linfa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wang Linfa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wang Linfa Today - Breaking & Trending Today

New Covid-19 variant may be of concern, but how big a threat it will be is unknown: Experts - Vimarsana News

New Covid-19 variant may be of concern, but how big a threat it will be is unknown: Experts

The new B.1.1.529 strain may soon be classified a variant of concern by the World Health Organisation. . Read more at straitstimes.com.

Future pandemic could stem from coronavirus transmitted from humans back to bat: Expert - Vimarsana News

Future pandemic could stem from coronavirus transmitted from humans back to bat: Expert

SINGAPORE (The Straits Times/Asia News Network): A new challenge that countries may possibly face in the future is the emergence of a new SARS-CoV-3 virus arising from humans transmitting the coronavirus back to bats.

Scientists Seek to Stop Pandemics With 'Last Booster You'll Ever Need' - Vimarsana News

Scientists Seek to Stop Pandemics With 'Last Booster You'll Ever Need'

In theory, vaccines could protect against lots of coronaviruses at once — but a working shot will require both lots of money and regulatory clearance.

Covid-19 virus changes shape for survival: Study - Vimarsana News

Covid-19 virus changes shape for survival: Study

Scientists in Singapore have made an important discovery about the shape and structure of the Sars-CoV-2 virus' genetic material - which can help in producing more effective drugs to treat Covid-19.. Read more at straitstimes.com.

Study points to a novel strategy for developing broad-spectrum vaccines against coronaviruses - Vimarsana News

Study points to a novel strategy for developing broad-spectrum vaccines against coronaviruses

Scientists from Duke-NUS Medical School and the National Centre for Infectious Diseases (NCID) found that 2003 SARS survivors who have been vaccinated with the Pfizer-BioNTech mRNA vaccine produced highly potent functional antibodies that are capable of neutralizing not only all known SARS-CoV-2 variants of concerns (VOCs) but also other animal coronaviruses that have the potential to cause human infection.